Nasal tanners contain a synthetic hormone called melanotan, which mimics the naturally occurring melanocyte-stimulating hormone (MSH) in the body
Its long-term safety profile is still under investigation
The issue of possible MDP variants is excellently discussed by Miller et al
Because retatrutide has shown highly promising results in clinical trials, and works on three receptors rather than two, many expect it could be priced higher than Mounjaro if it is approved
Healthcare providers should evaluate and manage factors that may impede progress, including: Medications that promote weight gain (certain antidepressants, antipsychotics, corticosteroids, insulin, beta-blockers) Undiagnosed or suboptimally treated hypothyroidism Sleep disorders, particularly obstructive sleep apnoea Psychological factors including depression, anxiety, and eating disorders Social and environmental barriers to lifestyle change Patients who have not achieved expected weight loss with single-agent therapy should undergo comprehensive reassessment before considering any treatment changes